Jump Financial, LLC Omeros Corp Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Oct 21, 2024	BUY	$2.48 - $5.22 $44,907 - $94,523	18,108 New	18,108 $84,000
Q1 2023 May 03, 2023	BUY	$2.48 - $5.22 $2,995 - $6,305	1,208 Added 7.15%	18,108 $84,000
Q4 2022 Feb 13, 2023	BUY	$1.75 - $3.96 $29,575 - $66,924	16,900 New	16,900 $38,000
Q2 2022 Aug 09, 2022	SELL	$1.92 - $6.28 $110,208 - $360,472	-57,400 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$5.07 - $7.2 $291,018 - $413,280	57,400 New	57,400 $345,000
Q3 2021 Nov 12, 2021	SELL	$13.4 - $16.3 $515,792 - $627,419	-38,492 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$14.81 - $19.13 $570,066 - $736,351	38,492 New	38,492 $571,000
Q1 2021 May 17, 2021	SELL	$14.52 - $23.53 $488,307 - $791,313	-33,630 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$10.14 - $15.19 $341,008 - $510,839	33,630 New	33,630 $481,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $747M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.